Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled trial of KL280006 injection for postoperative analgesia after pelvic or abdominal laparoscopic surgery
ChiCTR2200058157Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of KL280006 in postoperative pain (6 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Summed pain intensity difference within 24 hours after the end of the first postoperative administration. Started Jun 2020; status: completed.
02
Drugs
KL280006
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200058157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058157.